Yüklüyor......
Systemic therapy of hepatocellular carcinoma: Current status and future perspectives
The management of hepatocellular carcinoma (HCC) has substantially changed in the past few decades, the introduction of novel therapies (such as sorafenib) have improved patient survival. Nevertheless, HCC remains the third most common cause of cancer-related deaths worldwide. Decision-making largel...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Co., Limited
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3964381/ https://ncbi.nlm.nih.gov/pubmed/24696596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i12.3087 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|